Martingale Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-38,625	Closed	-$973K	–	795
2024 Q1	$973K	Sell	38,625 -30,465	-44%	-$720K	0.02%	478
2023 Q4	$2.24M	Sell	69,090 -160	-0.2%	-$4.39K	0.05%	263
2023 Q3	$1.89M	Sell	69,250 -9,512	-12%	-$275K	0.04%	280
2023 Q2	$1.75M	Buy	78,762 +4,013	+5%	+$92.4K	0.03%	305
2023 Q1	$1.62M	Buy	74,749 +1,088	+1%	+$23.9K	0.03%	319
2022 Q4	$1.5M	Buy	73,661 +2,603	+4%	+$65.2K	0.03%	339
2022 Q3	$1.82M	Buy	71,058 +306	+0.4%	+$8.19K	0.04%	270
2022 Q2	$1.68M	Buy	70,752 +57,028	+416%	+$1.24M	0.03%	323
2022 Q1	$310K	Sell	13,724 -53,242	-80%	-$1.13M	﹤0.01%	721
2021 Q4	$1.33M	Buy	66,966 +2,312	+4%	+$46.9K	0.02%	413
2021 Q3	$1.27M	Buy	+64,654	New	+$1.35M	0.02%	452